Gemcitabine and cisplatin in advanced non small cell lung cancer (NSCLC)

被引：0
|
作者：
Garcia-Gomez, R [1 ]
Lopez-Criado, P [1 ]
Guevara, S [1 ]
Lahoz, C [1 ]
Chaib, C [1 ]
Gonzalez, C [1 ]
Santiago, J [1 ]
De Alvaro, J [1 ]
Carrion, R [1 ]
Perez-Manga, G [1 ]
机构：
[1] Hosp Gen Gregorio Maranon, So Oncol Med, Madrid, Spain
来源：
ANNALS OF ONCOLOGY | 1998年 / 9卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
450
引用
下载
收藏
页码：93 / 94
页数：2
相关论文
共 50 条
  • [21] GEMCITABINE AND CISPLATIN (GC) PLUS MAINTENANCE THERAPY WITH SINGLE-AGENT GEMCITABINE IN PATIENTS WITH ADVANCED NON SMALL CELL LUNG CANCER (A-NSCLC)
    Papi, Maximilian
    Nicoletti, Stefania
    Drudi, Fabrizio
    Tamburini, Emiliano
    Gianni, Lorenzo
    Fantini, Manuela
    Nicolini, Mario
    Pasquini, Enzo
    Ravaioli, Alberto
    ANNALS OF ONCOLOGY, 2009, 20
  • [22] Cost-effectiveness of Gemcitabine (Gemzar™) plus cisplatin versus etoposide plus cisplatin for advanced non small cell lung cancer (NSCLC) in Spain
    Rosell, R
    Sacristan, JA
    Duthie, T
    Cardenal, F
    Artal, A
    Carrato, A
    Lomas, M
    Barneto, I
    Bameto, I
    Massuti, B
    ANNALS OF ONCOLOGY, 1998, 9 : 92 - 93
  • [23] Gemcitabine and cisplatin in a multimodality treatment for locally advanced non-small cell lung cancer
    C H Yang
    C M Tsai
    L S Wang
    Y C Lee
    C J Chang
    L T Lui
    S H Yen
    C Hsu
    A L Cheng
    M Y Liu
    S C Chiang
    Y M Chen
    K T Luh
    M H Huang
    P-C Yang
    R-P Perng
    British Journal of Cancer, 2002, 86 : 190 - 195
  • [24] Gemcitabine, vinorelbine and cisplatin combination chemotherapy in advanced non-small cell lung cancer
    Hasturk, S
    Hatabay, N
    Ece, F
    Karatas, M
    Hanta, I
    LUNG CANCER, 2005, 49 : S247 - S247
  • [25] Gemcitabine and cisplatin in a multimodality treatment for locally advanced non-small cell lung cancer
    Yang, CH
    Tsai, CM
    Wang, LS
    Lee, YC
    Chang, CJ
    Lui, LT
    Yen, SH
    Hsu, C
    Cheng, AL
    Liu, MY
    Chiang, SC
    Chen, YM
    Luh, KT
    Huang, MH
    Yang, PC
    Perng, RP
    BRITISH JOURNAL OF CANCER, 2002, 86 (02) : 190 - 195
  • [26] A novel biweekly schedule with cisplatin and gemcitabine in advanced non-small cell lung cancer
    López-Vivanco, G
    Fuente, N
    Barceló, R
    Rubio, I
    Muñoz, A
    Mañé, JM
    Pérez-Hoyos, T
    Viteri, A
    Ferreiro, J
    INTERNATIONAL JOURNAL OF CLINICAL PHARMACOLOGY RESEARCH, 2003, 23 (01) : 9 - 16
  • [27] Molecular markers in advanced non small cell lung cancer patients receiving gemcitabine & cisplatin
    Ismail, M.
    El Bastawisy, A.
    Gaafar, R.
    Bahnassy, A.
    Allahloubi, N.
    JOURNAL OF THORACIC ONCOLOGY, 2016, 11 (04) : S128 - S128
  • [28] Biweekly regimen of cisplatin, gemcitabine and vinorelbine for advanced non-small-cell lung cancer
    Javier Castro de Carpeño
    M. González Barón
    J. Aguiar
    J. I. Chacón
    J. Feliu
    M. J. García
    C. Madroñal
    A. Colmenarejo
    J. J. Sánchez
    A. Ordóñez
    Cancer Chemotherapy and Pharmacology, 2006, 58
  • [29] Biweekly regimen of cisplatin, gemcitabine and vinorelbine for advanced non-small-cell lung cancer
    de Carpeño, JC
    Barón, MG
    Aguiar, J
    Chacón, JI
    Feliu, J
    García, MJ
    Madroñal, C
    Colmenarejo, A
    Sánchez, JJ
    Ordóñez, A
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2006, 58 (02) : 266 - 271
  • [30] Prognostic value of performance status (PS) in advanced non-small cell lung cancer (NSCLC) patients receiving gemcitabine and cisplatin
    Gaafar, R
    Sallam, Y
    Khaled, H
    Mansour, O
    Abdel-Karim, N
    El-Attar, I
    LUNG CANCER, 2005, 49 : S390 - S390
12345